{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:33:58Z","timestamp":1791182038726,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.coi.2009.09.010","type":"journal-article","created":{"date-parts":[[2009,10,17]],"date-time":"2009-10-17T04:30:08Z","timestamp":1255753808000},"page":"708-714","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Are we ready to downregulate mast cells?"],"prefix":"10.1016","volume":"21","author":[{"given":"Laila","family":"Karra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Berent-Maoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha","family":"Ben-Zimra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Levi-Schaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2009.09.010_bib1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0014-4800(74)90059-8","article-title":"Mast cells: extended lifespan and lack of granule turnover under normal in vivo conditions","volume":"20","author":"Padawer","year":"1974","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.coi.2009.09.010_bib2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1006\/cimm.1993.1124","article-title":"Proliferation and functional responses of bone marrow-derived mast cells after activation","volume":"148","author":"Levi-Schaffer","year":"1993","journal-title":"Cell Immunol"},{"key":"10.1016\/j.coi.2009.09.010_bib3","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.4049\/jimmunol.145.10.3418","article-title":"Unresponsiveness of rat peritoneal mast cells to immunologic reactivation","volume":"145","author":"Levi-Schaffer","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2009.09.010_bib4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1067\/mai.2001.115753","article-title":"Autocrine regulation of cord blood-derived human mast cell activation by IL-10","volume":"108","author":"Royer","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2009.09.010_bib5","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/sj.cdd.4400598","article-title":"Caspase structure, proteolytic substrates, and function during apoptotic cell death","volume":"6","author":"Nicholson","year":"1999","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.coi.2009.09.010_bib6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0092-8674(00)80564-4","article-title":"Cell death in development","volume":"96","author":"Vaux","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.coi.2009.09.010_bib7","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1096\/fj.08-111005","article-title":"Life and death by death receptors","volume":"23","author":"Guicciardi","year":"2009","journal-title":"FASEB J"},{"key":"10.1016\/j.coi.2009.09.010_bib8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1011083031272","article-title":"Human mast cell apoptosis is regulated through Bcl-2 and Bcl-XL","volume":"21","author":"Mekori","year":"2001","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coi.2009.09.010_bib9","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.4049\/jimmunol.151.7.3775","article-title":"IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-Kit ligand","volume":"151","author":"Mekori","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2009.09.010_bib10","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1023\/A:1009680500988","article-title":"Regulation of apoptosis in mast cells","volume":"5","author":"Piliponsky","year":"2000","journal-title":"Apoptosis"},{"key":"10.1016\/j.coi.2009.09.010_bib11","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ctrv.2008.11.006","article-title":"TRAIL receptor signalling and modulation: are we on the right TRAIL?","volume":"35","author":"Mahalingam","year":"2009","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.coi.2009.09.010_bib12","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nrc821","article-title":"Targeting death and decoy receptors of the tumour-necrosis factor superfamily","volume":"2","author":"Ashkenazi","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.coi.2009.09.010_bib13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1044-5323(03)00033-2","article-title":"SHP-1: a regulator of neutrophil apoptosis","volume":"15","author":"Yousefi","year":"2003","journal-title":"Semin Immunol"},{"key":"10.1016\/j.coi.2009.09.010_bib14","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.4049\/jimmunol.169.10.5986","article-title":"Differential expression of TRAIL and TRAIL receptors in allergic asthmatics following segmental antigen challenge: evidence for a role of TRAIL in eosinophil survival","volume":"169","author":"Robertson","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2009.09.010_bib15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4414\/smw.2001.09707","article-title":"Alternative functions for TRAIL receptors in eosinophils and neutrophils","volume":"131","author":"Daigle","year":"2001","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.coi.2009.09.010_bib16","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0145-2126(88)90050-1","article-title":"Establishment of an immature mast cell line from a patient with mast cell leukemia","volume":"12","author":"Butterfield","year":"1988","journal-title":"Leuk Res"},{"key":"10.1016\/j.coi.2009.09.010_bib17_1","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.4049\/jimmunol.176.4.2272","article-title":"Human mast cells undergo TRAIL-induced apoptosis","volume":"176","author":"Berent-Maoz","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2009.09.010_bib18_1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1398-9995.2007.01598.x","article-title":"TRAIL mediated signaling in human mast cells: the influence of IgE-dependent activation","volume":"63","author":"Berent-Maoz","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.coi.2009.09.010_bib19","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.4049\/jimmunol.173.8.5247","article-title":"T cell proliferation by direct cross-talk between OX40 ligand on human mast cells and OX40 on human T cells: comparison of gene expression profiles between human tonsillar and lung-cultured mast cells","volume":"173","author":"Kashiwakura","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2009.09.010_bib20","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/sj.cdd.4401537","article-title":"Proapoptotic Bcl-2 family member Bim is involved in the control of mast cell survival and is induced together with Bcl-XL upon IgE-receptor activation","volume":"12","author":"Alfredsson","year":"2005","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.coi.2009.09.010_bib21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.1432-1327.1998.2540439.x","article-title":"Apoptosis signaling by death receptors","volume":"254","author":"Schulze-Osthoff","year":"1998","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.coi.2009.09.010_bib22","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.4049\/jimmunol.159.8.4006","article-title":"Fas (CD95, APO-1) antigen expression and function in murine mast cells","volume":"159","author":"Hartmann","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2009.09.010_bib23","doi-asserted-by":"crossref","first-page":"6262","DOI":"10.4049\/jimmunol.165.11.6262","article-title":"Enhanced expression of Fas-associated death domain-like IL-1-converting enzyme (FLICE)-inhibitory protein induces resistance to Fas-mediated apoptosis in activated mast cells","volume":"165","author":"Yoshikawa","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2009.09.010_bib24","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1084\/jem.192.8.1093","article-title":"Combined stimulation with the T helper cell type 2 cytokines interleukin (IL)-4 and IL-10 induces mouse mast cell apoptosis","volume":"192","author":"Yeatman","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2009.09.010_bib25","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1600-065X.2007.00510.x","article-title":"The mast cell IgG receptors and their roles in tissue inflammation","volume":"217","author":"Malbec","year":"2007","journal-title":"Immunol Rev"},{"key":"10.1016\/j.coi.2009.09.010_bib26","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1600-065X.2007.00522.x","article-title":"Inhibition of pathologic inflammation by leukocyte Ig-like receptor B4 and related inhibitory receptors","volume":"217","author":"Katz","year":"2007","journal-title":"Immunol Rev"},{"key":"10.1016\/j.coi.2009.09.010_bib27","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0952-7915(02)00400-4","article-title":"Inhibitory receptors and allergy","volume":"14","author":"Katz","year":"2002","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coi.2009.09.010_bib28","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0161-5890(02)00079-2","article-title":"Inhibition of anaphylactic inflammation by the gp49B1 receptor on mast cells","volume":"38","author":"Katz","year":"2002","journal-title":"Mol Immunol"},{"key":"10.1016\/j.coi.2009.09.010_bib29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1385\/IR:26:1-3:191","article-title":"Mast cell regulation via paired immunoglobulin-like receptor PIR-B","volume":"26","author":"Chen","year":"2002","journal-title":"Immunol Res"},{"key":"10.1016\/j.coi.2009.09.010_bib30","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S0161-5890(02)00080-9","article-title":"An unusual inhibitory receptor\u2014the mast cell function-associated antigen (MAFA)","volume":"38","author":"Abramson","year":"2002","journal-title":"Mol Immunol"},{"key":"10.1016\/j.coi.2009.09.010_bib31","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.it.2005.11.008","article-title":"Fc receptors as determinants of allergic reactions","volume":"27","author":"Kraft","year":"2006","journal-title":"Trends Immunol"},{"key":"10.1016\/j.coi.2009.09.010_bib32","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jaci.2007.10.017","article-title":"Accentuate the negative, eliminate the positive: engineering allergy therapeutics to block allergic reactivity through negative signaling","volume":"121","author":"Saxon","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2009.09.010_bib33_1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-065X.2008.00666.x","article-title":"Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future","volume":"224","author":"Daeron","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.coi.2009.09.010_bib34","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1002\/(SICI)1521-4141(199910)29:10<3148::AID-IMMU3148>3.0.CO;2-L","article-title":"Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells","volume":"29","author":"Cantoni","year":"1999","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.coi.2009.09.010_bib35","doi-asserted-by":"crossref","first-page":"7989","DOI":"10.4049\/jimmunol.175.12.7989","article-title":"The inhibitory receptor IRp60 (CD300a) is expressed and functional on human mast cells","volume":"175","author":"Bachelet","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2009.09.010_bib36","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1182\/blood-2005-07-2926","article-title":"The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophils","volume":"107","author":"Munitz","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.coi.2009.09.010_bib37","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.molimm.2007.05.006","article-title":"The CD300a (IRp60) inhibitory receptor is rapidly upregulated on human neutrophils in response to inflammatory stimuli and modulates CD32a (FcgammaRIIa) mediated signaling","volume":"45","author":"Alvarez","year":"2008","journal-title":"Mol Immunol"},{"key":"10.1016\/j.coi.2009.09.010_bib38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0165-2478(96)02654-5","article-title":"Selective in vivo recruitment of the phosphatidylinositol phosphatase SHIP by phosphorylated Fc gammaRIIB during negative regulation of IgE-dependent mouse mast cell activation","volume":"54","author":"Fong","year":"1996","journal-title":"Immunol Lett"},{"key":"10.1016\/j.coi.2009.09.010_bib39","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1172\/JCI117701","article-title":"Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors","volume":"95","author":"Daeron","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2009.09.010_bib40","doi-asserted-by":"crossref","first-page":"6327","DOI":"10.1074\/jbc.M006537200","article-title":"Insufficient phosphorylation prevents Fc gamma RIIB from recruiting the SH2 domain-containing protein-tyrosine phosphatase SHP-1","volume":"276","author":"Lesourne","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coi.2009.09.010_bib41_1","doi-asserted-by":"crossref","first-page":"6064","DOI":"10.4049\/jimmunol.180.9.6064","article-title":"Suppression of normal and malignant kit signaling by a bispecific antibody linking kit with CD300a","volume":"180","author":"Bachelet","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2009.09.010_bib42","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.4049\/jimmunol.162.8.4424","article-title":"Negative regulation of c-Kit-mediated cell proliferation by Fc gamma RIIB","volume":"162","author":"Malbec","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2009.09.010_bib43","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1182\/blood-2007-12-127951","article-title":"CD300a\/c regulate type I interferon and TNF-alpha secretion by human plasmacytoid dendritic cells stimulated with TLR7 and TLR9 ligands","volume":"112","author":"Ju","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.coi.2009.09.010_bib44","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0006-291X(03)01245-2","article-title":"Identification and characterization of a new pair of immunoglobulin-like receptors LMIR1 and 2 derived from murine bone marrow-derived mast cells","volume":"307","author":"Kumagai","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.coi.2009.09.010_bib45","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/nature04240","article-title":"Natural selection on protein-coding genes in the human genome","volume":"437","author":"Bustamante","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.coi.2009.09.010_bib46","doi-asserted-by":"crossref","first-page":"e170","DOI":"10.1371\/journal.pbio.0030170","article-title":"A scan for positively selected genes in the genomes of humans and chimpanzees","volume":"3","author":"Nielsen","year":"2005","journal-title":"PLoS Biol"},{"key":"10.1016\/j.coi.2009.09.010_bib47_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.it.2009.02.003","article-title":"The CD300 family of molecules are evolutionarily significant regulators of leukocyte functions","volume":"30","author":"Clark","year":"2009","journal-title":"Trends Immunol"},{"key":"10.1016\/j.coi.2009.09.010_bib48","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s00439-002-0851-y","article-title":"Novel immunoglobulin superfamily gene cluster, mapping to a region of human chromosome 17q25, linked to psoriasis susceptibility","volume":"112","author":"Speckman","year":"2003","journal-title":"Hum Genet"},{"key":"10.1016\/j.coi.2009.09.010_bib49","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/86867","article-title":"Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci","volume":"27","author":"Cookson","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.coi.2009.09.010_bib50","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1093\/hmg\/10.18.1901","article-title":"High resolution linkage and association mapping identifies a novel rheumatoid arthritis susceptibility locus homologous to one linked to two rat models of inflammatory arthritis","volume":"10","author":"Barton","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.coi.2009.09.010_bib51","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1398-9995.2006.01133.x","article-title":"Alteration and acquisition of Siglecs during in vitro maturation of CD34+ progenitors into human mast cells","volume":"61","author":"Yokoi","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.coi.2009.09.010_bib52","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1074\/jbc.275.2.861","article-title":"Siglec-8. A novel eosinophil-specific member of the immunoglobulin superfamily","volume":"275","author":"Floyd","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coi.2009.09.010_bib53","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1067\/mai.2000.107127","article-title":"Identification of SAF-2, a novel Siglec expressed on eosinophils, mast cells, and basophils","volume":"105","author":"Kikly","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2009.09.010_bib54","doi-asserted-by":"crossref","first-page":"5014","DOI":"10.1182\/blood-2002-10-3058","article-title":"Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis","volume":"101","author":"Nutku","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.coi.2009.09.010_bib55","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nri2056","article-title":"Siglecs and their roles in the immune system","volume":"7","author":"Crocker","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coi.2009.09.010_bib56","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2222.2008.03173.x","article-title":"Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors","volume":"39","author":"Bochner","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.coi.2009.09.010_bib57_1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jaci.2007.10.004","article-title":"Inhibition of FcepsilonRI-dependent mediator release and calcium flux from human mast cells by sialic acid-binding immunoglobulin-like lectin 8 engagement","volume":"121","author":"Yokoi","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2009.09.010_bib58","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1093\/glycob\/cwi097","article-title":"Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6\u2019-sulfo-sialyl Lewis X as a preferred glycan ligand","volume":"15","author":"Tateno","year":"2005","journal-title":"Glycobiology"},{"key":"10.1016\/j.coi.2009.09.010_bib59_1","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1002\/pmic.200800039","article-title":"Mucin-induced apoptosis of monocyte-derived dendritic cells during maturation","volume":"8","author":"Ishida","year":"2008","journal-title":"Proteomics"},{"key":"10.1016\/j.coi.2009.09.010_bib60","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000057747","article-title":"Detection of novel CD antigens on the surface of human mast cells and basophils","volume":"127","author":"Ghannadan","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.coi.2009.09.010_bib61","doi-asserted-by":"crossref","first-page":"32493","DOI":"10.1074\/jbc.274.45.32493","article-title":"Signal regulatory proteins negatively regulate immunoreceptor-dependent cell activation","volume":"274","author":"Lienard","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coi.2009.09.010_bib62","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1084\/jem.194.1.107","article-title":"The epithelial cellular adhesion molecule (Ep-CAM) is a ligand for the leukocyte-associated immunoglobulin-like receptor (LAIR)","volume":"194","author":"Meyaard","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2009.09.010_bib63","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1084\/jem.20052554","article-title":"Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1","volume":"203","author":"Lebbink","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2009.09.010_bib64","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1189\/jlb.0705398","article-title":"Identification of tyrosine residues crucial for CD200R-mediated inhibition of mast cell activation","volume":"79","author":"Zhang","year":"2006","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.coi.2009.09.010_bib65","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.4049\/jimmunol.174.3.1348","article-title":"The CD200 receptor is a novel and potent regulator of murine and human mast cell function","volume":"174","author":"Cherwinski","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2009.09.010_bib66","doi-asserted-by":"crossref","first-page":"6786","DOI":"10.4049\/jimmunol.173.11.6786","article-title":"Molecular mechanisms of CD200 inhibition of mast cell activation","volume":"173","author":"Zhang","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2009.09.010_bib67","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1615\/CritRevImmunol.v26.i3.20","article-title":"Is the CD200\/CD200 receptor interaction more than just a myeloid cell inhibitory signal?","volume":"26","author":"Minas","year":"2006","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.coi.2009.09.010_bib68","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1398-9995.2004.00332.x","article-title":"A bispecific antibody against human IgE and human FcgammaRII that inhibits antigen-induced histamine release by human mast cells and basophils","volume":"59","author":"Tam","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.coi.2009.09.010_bib69","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nm0502-518","article-title":"A novel human immunoglobulin Fc gamma Fc epsilon bifunctional fusion protein inhibits Fc epsilon RI-mediated degranulation","volume":"8","author":"Zhu","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2009.09.010_bib70","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jaci.2004.03.058","article-title":"Inhibition of allergen-specific IgE reactivity by a human Ig Fcgamma-Fcepsilon bifunctional fusion protein","volume":"114","author":"Zhang","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2009.09.010_bib71","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jaci.2007.08.051","article-title":"A mouse Fcgamma\u2013Fcepsilon protein that inhibits mast cells through activation of FcgammaRIIB, SH2 domain-containing inositol phosphatase 1, and SH2 domain-containing protein tyrosine phosphatases","volume":"121","author":"Mertsching","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2009.09.010_bib72","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jaci.2006.04.031","article-title":"Abrogation of allergic reactions by a bispecific antibody fragment linking IgE to CD300a","volume":"117","author":"Bachelet","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2009.09.010_bib73","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaci.2006.07.041","article-title":"Reversal of airway inflammation and remodeling in asthma by a bispecific antibody fragment linking CCR3 to CD300a","volume":"118","author":"Munitz","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2009.09.010_bib74","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1158\/0008-5472.CAN-07-6175","article-title":"Construction of optimized bispecific antibodies for selective activation of the death receptor CD95","volume":"68","author":"Herrmann","year":"2008","journal-title":"Cancer Res"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791509001873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791509001873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:29:43Z","timestamp":1760603383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791509001873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":74,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0952791509001873"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2009.09.010","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Are we ready to downregulate mast cells?","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2009.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}